HOLLIS EDEN PHARMACEUTICALS INC /DE/ 4
4 · HOLLIS EDEN PHARMACEUTICALS INC /DE/ · Filed Jan 22, 2008
Insider Transaction Report
Form 4
READING CHRISTOPHER
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2008-01-17+25,000→ 25,000 totalExercise: $1.62Exp: 2018-01-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option shall vest and become exercisable on the first anniversary of the date of grant. The balance of the shares shall vest and become exercisable in 36 equal monthly installments.